ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,522Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 2343

$1.5M Total Retail Price of All Prescriptions

Rank: 24 out of 2343

873 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 873 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

23% of this provider’s 873 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 20,993 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 1,537 1,096 1 1
OMEPRAZOLE 1,303 797 2 4
HYDROCODONE-ACETAMINOPHEN 1,293 730 S3 3 13
LISINOPRIL 1,024 609 4 3
FUROSEMIDE 990 768 5 6
LEVOTHYROXINE SODIUM 986 711 6 2
METOPROLOL TARTRATE 975 692 7 7
WARFARIN SODIUM 712 588 8 8
AMLODIPINE BESYLATE 614 459 9 5
ATENOLOL 586 333 10 12
ATORVASTATIN CALCIUM 585 460 11 10
METFORMIN HCL 568 381 12 9
GABAPENTIN 533 218 13 16
CITALOPRAM HBR 426 254 14 17
SPIRONOLACTONE 405 313 15 65
ZOLPIDEM TARTRATE 382 177 16 24
ISOSORBIDE MONONITRATE ER 352 271 17 32
MIRTAZAPINE 351 315 18 41
PANTOPRAZOLE SODIUM 340 248 19 22
AZITHROMYCIN 312 192 20 39
TAMSULOSIN HCL 289 212 21 29
ALENDRONATE SODIUM 287 240 22 28
ESCITALOPRAM OXALATE 264 234 23 55
OXYCODONE HCL 255 127 S2 24 67
SPIRIVA 244 142 25 48
PRANDIN 239 206 26 140
DIGOXIN 236 232 27 35
LANTUS 236 178 27 51
CLOPIDOGREL 231 172 29 26
TRAMADOL HCL 225 139 30 25
VENTOLIN HFA 207 113 31 79
POTASSIUM CHLORIDE 205 121 32 18
SERTRALINE HCL 204 146 33 20
TRAZODONE HCL 201 58 34 53
QUINAPRIL HCL 199 173 35 73
GLIPIZIDE 198 148 36 56
KLOR-CON M20 194 145 37 44
NAMENDA 191 190 38 36
HEPARIN SODIUM 186 180 39 198
DIOVAN 184 129 40 23
ADVAIR DISKUS 183 100 41 34
CARVEDILOL 180 129 42 27
INSULIN SYRINGE 178 110 43 102
LISINOPRIL-HYDROCHLOROTHIAZIDE 176 92 44 42
ALLOPURINOL 173 152 45 31
TRIAMTERENE-HCTZ 173 104 45 57
FAMOTIDINE 169 150 47 60
PLAVIX 161 125 48 38
DONEPEZIL HCL 150 146 49 21
AMIODARONE HCL 149 146 50 158
QUETIAPINE FUMARATE 149 124 50 77
OLANZAPINE 148 148 52 121
FENOFIBRATE 145 103 53 94
METOPROLOL SUCCINATE 129 82 54 14
IPRATROPIUM-ALBUTEROL 125 116 55 99
DOXAZOSIN MESYLATE 121 94 56 98
TRIAMCINOLONE ACETONIDE 121 85 56 137
POLYETHYLENE GLYCOL 3350 114 85 58 54
OXYCODONE-ACETAMINOPHEN 113 48 S2 59 49
ENALAPRIL MALEATE 109 92 60 58
RISPERIDONE 109 93 60 61
PREDNISONE 107 60 62 37
FENTANYL 105 64 S2 63 69
EXELON 102 95 64 129
GLIPIZIDE XL 100 75 65 84
RANITIDINE HCL 96 59 66 43
OXYBUTYNIN CHLORIDE 94 76 67 169
BUMETANIDE 94 80 67 91
TRICOR 93 59 69 96
LOSARTAN POTASSIUM 93 77 69 19
DILTIAZEM 24HR ER 92 82 71 76
NOVOLOG 92 69 71 110
FLUTICASONE PROPIONATE 91 46 73 46
SINGULAIR 90 66 74 100
BUSPIRONE HCL 90 58 74 146
CYCLOBENZAPRINE HCL 90 27 R 74 109
COMBIVENT 89 74 77 144
HUMALOG 85 56 78 131
VENLAFAXINE HCL ER 84 36 79 87
OXYBUTYNIN CHLORIDE ER 83 78 80 149
VESICARE 82 58 81 145
PAROXETINE HCL 81 44 82 66
CELEBREX 80 40 83 71
LEVETIRACETAM 78 46 84 104
FLUOXETINE HCL 77 37 85 82
LANTUS SOLOSTAR 77 57 85 101
HYDROCHLOROTHIAZIDE 75 50 87 11
LIPITOR 75 59 87 78
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 48 89 120
PRAVASTATIN SODIUM 73 40 89 15
GEMFIBROZIL 72 18 91 133
HYDRALAZINE HCL 72 46 91 92
CLONIDINE HCL 71 47 93 70
PROAIR HFA 71 40 93 86
DIVALPROEX SODIUM 70 32 95 105
LACTULOSE 69 30 96 139
AMOX TR-POTASSIUM CLAVULANATE 68 46 97 160
CYMBALTA 68 54 97 74
ROPINIROLE HCL 68 45 97 124
NITROGLYCERIN PATCH 67 65 100 147
FINASTERIDE 65 64 101 80
CLOTRIMAZOLE-BETAMETHASONE 65 55 101 127
CEPHALEXIN 63 42 103 111
MONTELUKAST SODIUM 62 38 104 181
LANSOPRAZOLE 62 34 104 162
CARISOPRODOL 61 24 R 106 176
ZOSTAVAX 59 48 107 236
CARBIDOPA-LEVODOPA 58 58 108 85
DETROL LA 58 36 108 150
PHENYTOIN SODIUM EXTENDED 54 11 110 152
VERAPAMIL ER 53 49 111 95
NAPROXEN 52 36 112 108
PROCHLORPERAZINE MALEATE 52 24 112 287
LEVOFLOXACIN 51 37 114 106
KLOR-CON M10 50 36 115 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.